NBSE — NeuBase Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for NeuBase Therapeutics, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2018 September 30th	2019 September 30th	2020 September 30th	2021 September 30th	2022 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	3.75	10.3	32	52.9	23.2
Prepaid Expenses
Total Current Assets	4	11	32.8	54.9	24.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.016	0.431	1.17	8.41	7.77
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	11.6	12.5	34.4	64.2	32.7
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.725	2.5	3.15	4.19	4.17
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.725	2.5	3.15	10.1	9.5
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	10.9	10	31.3	54.1	23.2
Total Liabilities & Shareholders' Equity	11.6	12.5	34.4	64.2	32.7
Total Common Shares Outstanding
Total Preferred Shares Outstanding